Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» NASDAQ
NASDAQ
Seneca Biopharma merges with Leading BioSciences, becoming Palisade Bio
Fierce Biotech
Thu, 12/17/20 - 11:09 am
Seneca Biopharma
Leading BioSciences
Palisade Bio
NASDAQ
M&A
BioAtla heads for Nasdaq on Wednesday following $189M IPO, going public with its pH-detecting cancer treatments
Endpoints
Wed, 12/16/20 - 11:32 am
BioAtla
IPOs
NASDAQ
Kinnate Biopharma upsizes IPO and prices above range at $20 a share
Marketwatch
Fri, 12/4/20 - 10:53 am
Kinnate Biopharma
IPOs
NASDAQ
small molecule kinase inhibitors
Pfizer Spinoff Cerevel Therapeutics Begins Trading on the Nasdaq
BioSpace
Wed, 10/28/20 - 11:09 pm
Pfizer
Cerevel Therapeutics
SPAC
Arya Sciences
NASDAQ
Foghorn hits Nasdaq in $120M debut as the biotech IPO boom shows no sign of slowing
Endpoints
Fri, 10/23/20 - 11:57 am
Foghorn Therapeutics
IPOs
NASDAQ
chromatin regulatory system
Eargo soars after announcing $141.3M IPO
Mass Device
Mon, 10/19/20 - 10:45 am
Eargo
IPOs
hearing devices
NASDAQ
devices
Kronos Bio sets terms for IPO, flirting with billion-dollar unicorn valuation
Endpoints
Mon, 10/5/20 - 11:50 am
IPOs
Kronos Bio
NASDAQ
Bischofberger's Kronos files for IPO to run pivotal cancer trial
Fierce Biotech
Mon, 09/21/20 - 10:31 am
Kronos Bio
IPO
NASDAQ
AML
Kymera, raising $173M+, becomes the 48th biotech IPO of the year as 2020 surpasses 2019
Endpoints
Fri, 08/21/20 - 12:06 pm
Kymera
IPOs
NASDAQ
Three more biotechs tumble onto Wall Street today, raising $475M as the IPO party rocks on
Endpoints
Fri, 07/17/20 - 10:52 am
IPOs
ALX Oncology
Berkeley Lights
Pandion Therapeutics
NASDAQ
Chinese Biotech Beigene to Raise $2.1 Billion in Share Sale
Bloomberg
Mon, 07/13/20 - 11:07 am
China
BeiGene
Amgen
NASDAQ
Royalty Pharma scores $2.2B IPO — the biggest of the year
Endpoints
Tue, 06/16/20 - 10:44 am
Royalty Pharma
IPOs
NASDAQ
Royalty Pharma plans largest IPO of the year so far
Pharmaforum
Wed, 06/10/20 - 10:46 am
Royalty Pharma
IPOs
NASDAQ
Add ear gene therapy company Akouos to the ever-growing list of IPOs amid Covid-19
Endpoints
Mon, 06/8/20 - 10:26 am
IPOs
Akouos
NASDAQ
gene therapy
hearing loss
Biotech IPO bonanza: Legend's $350M offering as Repare, Forma get in on the action
Fierce Biotech
Mon, 06/1/20 - 10:56 am
Legend Biotech
IPOs
GenScript
NASDAQ
IPOs abound in the time of coronavirus, as Forma Therapeutics pencils in $150M Nasdaq debut
Endpoints
Mon, 06/1/20 - 10:48 am
IPOs
NASDAQ
Forma Therapeutics
Bristol-Myers Squibb
COVID-19
AstraZeneca-partnered RNA player Silence plans Nasdaq listing
Fierce Biotech
Wed, 05/20/20 - 10:45 am
Silence Therapeutics
RNA therapeutics
RNA
NASDAQ
AstraZeneca
gene silencing
Biotech J&J-backed CAR-T biotech Legend guns for $100M IPO but sees CRS death in early trial
Fierce Biotech
Thu, 05/14/20 - 10:23 am
IPOs
Legend Biotech
cell therapy
NASDAQ
China
Analysis shows Swiss biotech index outshines Nasdaq counterpart, but coronavirus challenges are universal
Endpoints
Wed, 04/22/20 - 10:26 pm
biotech
NASDAQ
Switzerland
pandemic
COVID-19
Report: Congressman wants SEC investigation into Gilead Covid-19 data leak
MedCity News
Tue, 04/21/20 - 12:13 pm
legal
SEC
Gilead Sciences
remdesivir
NASDAQ
COVID-19
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »